G. P. Katsoulotos
Camden and Campbelltown Hospitals(AU)St George Hospital(AU)
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Respiratory and Cough-Related Research, Occupational exposure and asthma, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry(2016)81 cited
- → Real‐life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria(2016)37 cited
- Clinical Effectiveness Of Omalizumab In Severe Allergic Asthma Above The Recommended Dosing Range: The Australian Xolair Registry(2016)